BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 17459030)

  • 21. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
    Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
    Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistence of triamcinolone acetonide following macular hole surgery.
    Yamauchi Y; Nakamura H; Hayakawa K; Sawaguchi S
    Acta Ophthalmol Scand; 2006 Oct; 84(5):711-2. PubMed ID: 16965509
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonprogressive extrafoveal retinal hole after foveal epiretinal membrane removal.
    Kozak I; Freeman WR
    Am J Ophthalmol; 2006 Apr; 141(4):769-71. PubMed ID: 16564828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Atypical macular holes].
    Brüggemann A; Hoerauf H
    Klin Monbl Augenheilkd; 2008 Apr; 225(4):281-5. PubMed ID: 18401794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravitreal triamcinolone versus laser photocoagulation for persistent diabetic macular oedema.
    Ockrim ZK; Sivaprasad S; Falk S; Roghani S; Bunce C; Gregor Z; Hykin P
    Br J Ophthalmol; 2008 Jun; 92(6):795-9. PubMed ID: 18420749
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intravitreal triamcinolone acetonide injections in treatment of cystoid macular edema due to diabetic maculopathy].
    Lubczyńska A; Kociecki J
    Klin Oczna; 2007; 109(4-6):165-8. PubMed ID: 17725277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetic-pharmacodynamic modeling of the effect of triamcinolone acetonide on central macular thickness in patients with diabetic macular edema.
    Audren F; Tod M; Massin P; Benosman R; Haouchine B; Erginay A; Caulin C; Gaudric A; Bergmann JF
    Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3435-41. PubMed ID: 15452046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Posterior juxtascleral infusion of modified triamcinolone acetonide formulation for refractory diabetic macular edema: one-year follow-up.
    Veritti D; Lanzetta P; Perissin L; Bandello F
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2391-7. PubMed ID: 19117937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herpes simplex keratitis after intravitreal triamcinolone acetonide.
    Shtein RM; Stahl RM; Saxe SJ; Mian SI
    Cornea; 2007 Jun; 26(5):641-2. PubMed ID: 17525670
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Residual triamcinolone acetonide sequestered in the fovea after macular hole repair.
    Payne JF; Bergstrom C; Yan J; Aaberg TM; Srivastava SK
    Retina; 2011 Jan; 31(1):148-53. PubMed ID: 20921926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surgical treatment of diabetic macular oedema].
    Gamulescu MA; Herrmann WA; Helbig H
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):910-3. PubMed ID: 19757353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcomes of macular hole surgery with triamcinolone acetonide-assisted internal limiting membrane peeling.
    Kumagai K; Furukawa M; Ogino N; Larson E; Uemura A
    Retina; 2007; 27(9):1249-54. PubMed ID: 18046233
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistent triamcinolone acetonide particles on the posterior lens capsule after intravitreal injection.
    Sakalar YB; Unlu K; Keklikci U; Caca I; Senol BB
    Ann Ophthalmol (Skokie); 2008; 40(3-4):190-2. PubMed ID: 19230363
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Triamcinolone in the treatment of the diabetic macular edema--one-year results].
    Dusová J; Studnicka J; Rencová E; Korda V; Hejcmanová D
    Cesk Slov Oftalmol; 2008 Jul; 64(4):149-52. PubMed ID: 18780654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spectral-domain optical coherence tomography use in macular diseases: a review.
    Wolf S; Wolf-Schnurrbusch U
    Ophthalmologica; 2010; 224(6):333-40. PubMed ID: 20453539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetic macular edema.
    Gillies M
    Ophthalmology; 2009 Mar; 116(3):595; author reply 596-7. PubMed ID: 19264220
    [No Abstract]   [Full Text] [Related]  

  • 37. Improvement of visual acuity one-year after vitreous surgery in eyes with residual triamcinolone acetonide at the macular hole.
    Hikichi T; Furukawa Y; Ohtsuka H; Higuchi M; Matsushita T; Ariga H; Kosaka S; Matsushita R
    Am J Ophthalmol; 2008 Feb; 145(2):267-272. PubMed ID: 18054886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravitreal triamcinolone in two patients with refractory macular oedema in sarcoid uveitis.
    Larsson J; Hvarfner C; Skarin A
    Acta Ophthalmol Scand; 2005 Oct; 83(5):618-9. PubMed ID: 16188004
    [No Abstract]   [Full Text] [Related]  

  • 39. Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa.
    Kim JE
    Retina; 2006; 26(9):1094-6. PubMed ID: 17151506
    [No Abstract]   [Full Text] [Related]  

  • 40. Lamellar macular holes: tomographic features and surgical outcome.
    Androudi S; Stangos A; Brazitikos PD
    Am J Ophthalmol; 2009 Sep; 148(3):420-6. PubMed ID: 19493523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.